KATHERINE SCHMITZ: Open Payments
NPI 1336838051 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 45 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $145 |
| AstraZeneca Pharmaceuticals LP | 7 | $131 |
| Novo Nordisk Inc | 5 | $104 |
| Noven Therapeutics, LLC | 3 | $66 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 4 | $59 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Abbott Laboratories | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: VRAYLAR, Wegovy, Xelstrym, FARXIGA, NEXLETOL, OTEZLA, FREESTYLE LIBRE 3, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
